TREATMENT PATTERNS IN PATIENTS WITH CHRONIC-PHASE CHRONIC MYELOID LEUKAEMIA IN ROUTINE CLINICAL PRACTICE: THE SIMPLICITY ITALIAN POPULATION

E. Abruzzese,Alberto Bosi,Massimo Breccia,Mariella D’Adda,Nicola Di Renzo,Anna Marina Liberati,Raffaele Porrini,Ester Orlandi,Fabrizio Pane,Ester Pungolino,Federica Sorà,Fabio Stagno,Ginny P. Sen,Fabiana Gentilini,F De Solda,Carlo Gambacorti-Passerini

TREATMENT PATTERNS IN PATIENTS WITH CHRONIC-PHASE CHRONIC MYELOID LEUKAEMIA IN ROUTINE CLINICAL PRACTICE: THE SIMPLICITY ITALIAN POPULATION

2019

E. Abruzzese
Alberto Bosi
Massimo Breccia
Mariella D’Adda
Nicola Di Renzo
Anna Marina Liberati
Raffaele Porrini
Ester Orlandi
Fabrizio Pane
Ester Pungolino
Federica Sorà
Fabio Stagno
Ginny P. Sen
Fabiana Gentilini
F De Solda
Carlo Gambacorti-Passerini

Background and Objectives While tyrosine kinase inhibitors (TKIs) have transformed CP-CML management, limited data exist on their use in clinical practice.

Keywords:

Immunology
Clinical Practice
Medicine
Population
Chronic phase chronic myeloid leukaemia
Internal medicine
Nilotinib
routine clinical practice
Imatinib
Observational study
Dasatinib
Pediatrics
Cohort

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations